{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T04:55:07Z","timestamp":1785732907482,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T00:00:00Z","timestamp":1729209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005049","name":"Science and Engineering Research Council","doi-asserted-by":"publisher","award":["EP\/Y014596\/1"],"award-info":[{"award-number":["EP\/Y014596\/1"]}],"id":[{"id":"10.13039\/501100005049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000266","name":"Engineering and Physical Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000266","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003776","name":"Newcastle Upon Tyne Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","award":["BF2924"],"award-info":[{"award-number":["BF2924"]}],"id":[{"id":"10.13039\/501100003776","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ajog.2024.10.023","type":"journal-article","created":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T11:37:40Z","timestamp":1729510660000},"page":"474.e1-474.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["A randomized crossover design study comparing the pharmacokinetics and pharmacodynamics of 2 single doses of oral aspirin (75\u00a0mg v 150 mg) in pregnant women at risk of preeclampsia: implications on assessing aspirin response and patient adherence to therapy"],"prefix":"10.1016","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9375-7915","authenticated-orcid":false,"given":"Raya","family":"Vinogradov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ois\u00edn N.","family":"Kavanagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Robson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.10.023_bib1","series-title":"NICE Guideline 133: Hypertension in Pregnancy: Diagnosis and Management","year":"2019"},{"key":"10.1016\/j.ajog.2024.10.023_bib2","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"US Preventive Services Task Force","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2024.10.023_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101000","article-title":"Comparing aspirin 75 to 81 mg vs 150 to 162 mg for prevention of preterm preeclampsia: systematic review and meta-analysis","volume":"5","author":"Ghesquiere","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2024.10.023_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.11.062","article-title":"Aspirin 162 mg versus 81 mg for preeclampsia prophylaxis in high-risk obese individuals: a comparative effectiveness open label randomized trial (ASPREO)","author":"Amro","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jps.2600610312","article-title":"Absorption kinetics of aspirin in man follow oral administration of an aqueous solution","volume":"61","author":"Rowland","year":"1972","journal-title":"J\u00a0Pharmaceut Sci"},{"key":"10.1016\/j.ajog.2024.10.023_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1542\/peds.62.5S.867","article-title":"Clinical pharmacokinetics of aspirin","volume":"62","author":"Levy","year":"1978","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.10.023_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.10.023_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejogrb.2011.02.026","article-title":"Is testing for aspirin response worthwhile in high-risk pregnancy?","volume":"157","author":"Rey","year":"2011","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.023_bib9","first-page":"334","article-title":"Aspirin resistance may be associated with adverse pregnancy outcomes","volume":"32","author":"W\u00f3jtowicz","year":"2011","journal-title":"Neuroendocrinol Lett"},{"key":"10.1016\/j.ajog.2024.10.023_bib10","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/S1701-2163(16)34346-8","article-title":"Low-dose ASA response using the PFA-100 in women with high-risk pregnancy","volume":"31","author":"Caron","year":"2009","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2024.10.023_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ejogrb.2020.09.036","article-title":"Aspirin non-response in pregnant women at increased risk of pre-eclampsia","volume":"254","author":"Vinogradov","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2024.10.023_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2019.04.027","article-title":"A\u00a0pharmacokinetic assessment of optimal dosing, preparation, and chronotherapy of aspirin in pregnancy","volume":"221","author":"Shanmugalingam","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib13","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3109\/07420528.2012.717455","article-title":"Chronotherapy with low-dose aspirin for prevention of complications in pregnancy","volume":"3","author":"Ayala","year":"2013","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.ajog.2024.10.023_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.10.023_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2024.10.023_bib16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1097\/00001888-199409000-00005","article-title":"The industry perspective on the inclusion of women in clinical trials","volume":"69","author":"Bush","year":"1994","journal-title":"Acad Med"},{"key":"10.1016\/j.ajog.2024.10.023_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fdsfr.2023.1187070","article-title":"Specialty grand challenge editorial innovative approaches for pharmacoepidemiologic research in pregnancy: shifting the paradigm of Thalidomide\u2019s impact on pregnant women","volume":"3","author":"Gerbier","year":"2023","journal-title":"Front Drug Saf Regul"},{"key":"10.1016\/j.ajog.2024.10.023_bib18","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/jth.12637","article-title":"Reappraisal of the clinical pharmacology of low-dose aspirin by comparing novel direct and traditional indirect biomarkers of drug action","volume":"12","author":"Patrignani","year":"2014","journal-title":"J\u00a0Thromb Haemostasis"},{"key":"10.1016\/j.ajog.2024.10.023_bib19","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1213\/ANE.0000000000001143","article-title":"Pharmacokinetics and pharmacodynamics of drugs commonly used in pregnancy and parturition","volume":"122","author":"Ansari","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1016\/j.ajog.2024.10.023_bib20","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.111.1.e77","article-title":"Low-dose aspirin in pregnancy: maternal and neonatal aspirin concentrations and neonatal prostanoid formation","volume":"111","author":"Leonhardt","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2024.10.023_bib21","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.amjcard.2009.04.027","article-title":"Aspirin resistance in healthy drug-naive men versus women (from the heredity and phenotype intervention heart study)","volume":"104","author":"Shen","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ajog.2024.10.023_bib22","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0002-9378(98)70130-9","article-title":"Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial","volume":"179","author":"Hauth","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2024.10.023_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/0002-9378(95)90285-6","article-title":"Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial","volume":"173","author":"Hauth","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib25","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1161\/01.CIR.72.6.1177","article-title":"Clinical pharmacology of platelet cyclooxygenase inhibition","volume":"72","author":"C","year":"1985","journal-title":"Circulation"},{"key":"10.1016\/j.ajog.2024.10.023_bib26","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.thromres.2011.01.005","article-title":"Thromboxane metabolite excretion during pregnancy- influence of preeclampsia and aspirin treatment","volume":"127","author":"Perneby","year":"2011","journal-title":"Thromb Res"},{"key":"10.1016\/j.ajog.2024.10.023_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.100878","article-title":"Low-dose asprin use during pregnancy may be a potential risk for postpartum hemorrhage and increased blood loss: a systematic review and meta-analysis","volume":"5","author":"Jiang","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2024.10.023_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/uog.27472","article-title":"Propensity score analysis of low-dose aspirin and bleeding complications in pregnancy","volume":"63","author":"Souter","year":"2024","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2024.10.023_bib31","first-page":"1025","article-title":"Preconceptional and maternal obesity: epidemiology and health consequences","volume":"4","author":"Poston","year":"2016","journal-title":"Lancet\u00a0Diabetes Endocrinol"},{"key":"10.1016\/j.ajog.2024.10.023_bib32","series-title":"NHS Maternity Care for Women with a Body Mass Index of 30 kg\/m2 or Above: Births between 1 April 2015 and 31 March 2017 in England, Wales and Scotland","author":"Relph","year":"2021"},{"key":"10.1016\/j.ajog.2024.10.023_bib33","article-title":"Aspirin pharmacokinetics and pharmacodynamics through gestation","volume":"231","author":"Rupsa","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.10.023_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2017.07.038","article-title":"Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history","volume":"217","author":"Poon","year":"2017","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824010846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824010846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:37:50Z","timestamp":1762079870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824010846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0002937824010846"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.023","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized crossover design study comparing the pharmacokinetics and pharmacodynamics of 2 single doses of oral aspirin (75\u00a0mg v 150 mg) in pregnant women at risk of preeclampsia: implications on assessing aspirin response and patient adherence to therapy","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}